Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial
Fujiwara, Keiichi, Fujiwara, Hiroyuki, Yoshida, Hiroyuki, Satoh, Toyomi, Yonemori, Kan, Nagao, Shoji, Matsumoto, Takashi, Kobayashi, Hiroaki, Bourgeois, Hughes, Harter, Philipp, Mosconi, Anna Maria, Vazquez, Isabel Palacio, Reinthaller, Alexander, Fujita, Tomoko, Rowe, Philip, Pujade-Lauraine, Eric, Ray-Coquard, Isabelle
Published in Journal of gynecologic oncology (01.09.2021)
Published in Journal of gynecologic oncology (01.09.2021)
Get full text
Journal Article
Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial
Keiichi Fujiwara, Hiroyuki Fujiwara, Hiroyuki Yoshida, Toyomi Satoh, Kan Yonemori, Shoji Nagao, Takashi Matsumoto, Hiroaki Kobayashi, Hughes Bourgeois, Philipp Harter, Anna Maria Mosconi, Isabel Palacio Vazquez, Alexander Reinthaller, Tomoko Fujita, Philip Rowe, Eric Pujade-lauraine, Isabelle Ray-coquard
Published in Journal of gynecologic oncology (01.09.2021)
Get full text
Published in Journal of gynecologic oncology (01.09.2021)
Journal Article